Previous
Atletico Madrid
Malmo FF
ESPN3 6:45 PM GMT
Game Details
Olympiakos
Juventus
6:45 PM GMT
Game Details
Liverpool
Real Madrid
6:45 PM GMT
Game Details
Ludogorets Razgrad
FC Basel
ESPN3 6:45 PM GMT
Game Details
AS Monaco
Benfica
ESPN3 6:45 PM GMT
Game Details
Bayer Leverkusen
Zenit St Petersburg
ESPN3 6:45 PM GMT
Game Details
Anderlecht
Arsenal
ESPN3 6:45 PM GMT
Game Details
Galatasaray
Borussia Dortmund
ESPN3 6:45 PM GMT
Game Details
Next
Jul 24, 2013

PSG dismiss Marquinhos concerns

Paris Saint-Germain have dismissed concerns over the health of Brazilian defender Marquinhos, who completed a €35 million move to the French champions last week.

• Johnson: Time to focus on season

The 19-year-old centre-back stayed in the French capital while the rest of the squad travelled to play two friendly matches in Sweden.

According to Le Parisien, Marquinhos could be suffering from a form of hepatitis, citing a source close to the player who is based in his homeland.

However, the club denied that rumour and told Le Parisien that he would resume training with the team on Monday after the bulk of the squad returns from Sweden.

The paper says that Marquinhos has also been troubled by mouth ulcers and that he went through a more vigorous medical examination than usual before his transfer was completed on Friday. Before joining PSG, staff at his former club Roma reported that he was ill during their training camp in the North of Italy.

The centre-back was PSG’s third signing of the summer after striker Edinson Cavani and full-back Lucas Digne, bringing the club’s spending to well over €100 million.

According to L’Equipe, PSG were also forced to increase centre-back Thiago Silva’s salary by €1.5 million per year to ward off interest from Barcelona.

Comments

Use a Facebook account to add a comment, subject to Facebook's Terms of Service and Privacy Policy. Your Facebook name, photo & other personal information you make public on Facebook will appear with your comment, and may be used on ESPN's media platforms. Learn more.